AAAAAA
Results:
1-7
|
Results: 7
Authors:
Hagve, TA
Narce, M
Tjonneland, SE
Odden, N
Liabo, J
Poisson, JP
Citation: Ta. Hagve et al., Desaturation and esterification of fatty acids in kidney cells from spontaneously hypertensive rats, SC J CL INV, 61(2), 2001, pp. 151-159
Authors:
Holven, KB
Holm, T
Aukrust, P
Christensen, B
Kjekshus, J
Andreassen, AK
Gullestad, L
Hagve, TA
Svilaas, A
Ose, L
Nenseter, MS
Citation: Kb. Holven et al., Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjects, AM J MED, 110(7), 2001, pp. 536-542
Authors:
Nenseter, MS
Osterud, B
Larsen, T
Strom, E
Bergei, C
Hewitt, S
Holven, KB
Hagve, TA
Mjos, SA
Solvang, M
Petterson, J
Opstvedt, J
Ose, L
Citation: Ms. Nenseter et al., Effect of Norwegian fish powder on risk factors for coronary heart diseaseamong hypercholesterolemic individuals, NUTR MET CA, 10(6), 2000, pp. 323-330
Authors:
Mehlum, A
Gjernes, E
Solberg, LA
Hagve, TA
Prydz, H
Citation: A. Mehlum et al., Overexpression of human lecithin : cholesterol acyltransferase in mice offers no protection against diet-induced atherosclerosis, APMIS, 108(5), 2000, pp. 336-342
Authors:
Baksaas, ST
Videm, V
Fosse, E
Karlsen, H
Pedersen, T
Mollnes, TE
Hagve, TA
Svennevig, JL
Citation: St. Baksaas et al., In vitro evaluation of new surface coatings for extracorporeal circulation, PERFUSION-U, 14(1), 1999, pp. 11-19
Authors:
Videm, V
Mollnes, TE
Fosse, E
Mohr, B
Bergh, K
Hagve, TA
Aasen, AO
Svennevig, JL
Citation: V. Videm et al., Heparin-coated cardiopulmonary bypass equipment. I. Biocompatibility markers and development of complications in a high-risk population, J THOR SURG, 117(4), 1999, pp. 794-802
Authors:
Videm, V
Mollnes, TE
Bergh, K
Fosse, E
Mohr, B
Hagve, TA
Aasen, AO
Svennevig, JL
Citation: V. Videm et al., Heparin-coated cardiopulmonary bypass equipment. II. Mechanisms for reduced complement activation in vivo, J THOR SURG, 117(4), 1999, pp. 803-809
Risultati:
1-7
|